Trials / Completed
CompletedNCT05841043
Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease
A Multi-Center, Randomized, Double-masked, Vehicle-Controlled Phase III Clinical Study to Assess the Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 206 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to assess the efficacy, safety and tolerability of SHR8028 eye drops in comparison to the vehicle for the treatment of dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR8028 eye drops | SHR8028 eye drops |
| DRUG | Vehicle eye drops. | Vehicle eye drops. |
Timeline
- Start date
- 2021-03-04
- Primary completion
- 2022-04-02
- Completion
- 2022-07-22
- First posted
- 2023-05-03
- Last updated
- 2023-05-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05841043. Inclusion in this directory is not an endorsement.